Enclosed herewith Unaudited Financial Result along with Limited Review Report for quarter Ended 31st December 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Family Care Hospitals (formerly Scandent Imaging) reported Q3 FY26 revenue from operations of ₹6.01 lakhs versus ₹2.83 lakhs in Q3 FY25, but 9-month FY26 revenue dropped sharply to ₹15.11 lakhs from ₹788.03 lakhs in 9M FY25. The company posted a net loss of ₹95.74 lakhs in Q3 FY26 and ₹625.98 lakhs for 9M FY26, narrower than the ₹4,513.59 lakh loss in 9M FY25 (which had a large exceptional item of ₹7,462 lakhs). EPS stood at ₹(0.18) for the quarter and ₹(1.16) for 9M FY26. The auditor drew attention to the issue of 1,86,77,500 share warrants on a preferential basis, of which ₹4.67 crore (25%) has been received; the auditor confirmed the conclusion is not qualified. No outstanding loan or debt defaults exist as on December 31, 2025.
Operating revenue is negligible and down sharply year-on-year, indicating the core healthcare business is generating almost no income, though losses have narrowed from prior-year exceptional charges. The share warrant allotment signals an upcoming equity infusion, but existing shareholders face continued losses and very weak operational performance.